These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 16128233)

  • 21. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
    Leelakanok N; Geary SM; Salem AK
    J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders.
    Kang J; Lambert O; Ausborn M; Schwendeman SP
    Int J Pharm; 2008 Jun; 357(1-2):235-43. PubMed ID: 18384984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis.
    Zhang Y; Zale S; Sawyer L; Bernstein H
    J Biomed Mater Res; 1997 Mar; 34(4):531-8. PubMed ID: 9054536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin.
    Hussein AS; Abdullah N; Ahmadun FR
    IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of soluble, salt-loaded, degradable PLGA films and their release of tetracycline.
    Webber WL; Lago F; Thanos C; Mathiowitz E
    J Biomed Mater Res; 1998 Jul; 41(1):18-29. PubMed ID: 9641620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
    Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
    J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
    Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
    Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.
    Lin Y; Li Y; Ooi CP
    J Mater Sci Mater Med; 2012 Oct; 23(10):2453-60. PubMed ID: 22843166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
    Desai KG; Mallery SR; Schwendeman SP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The microclimate pH in poly(D,L-lactide-co-hydroxymethyl glycolide) microspheres during biodegradation.
    Liu Y; Ghassemi AH; Hennink WE; Schwendeman SP
    Biomaterials; 2012 Oct; 33(30):7584-93. PubMed ID: 22819499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J; Wang BM; Schwendeman SP
    Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Size effect of PLGA spheres on drug loading efficiency and release profiles.
    Dawes GJ; Fratila-Apachitei LE; Mulia K; Apachitei I; Witkamp GJ; Duszczyk J
    J Mater Sci Mater Med; 2009 May; 20(5):1089-94. PubMed ID: 19160026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J; Wang BM; Schwendeman SP
    J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fabrication and characterization of controlled release poly(D,L-lactide-co-glycolide) millirods.
    Qian F; Szymanski A; Gao J
    J Biomed Mater Res; 2001 Jun; 55(4):512-22. PubMed ID: 11288079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery.
    Chowdhury DK; Mitra AK
    Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of the initial stages of drug release from a degradable matrix of poly(d,l-lactide-co-glycolide).
    Frank A; Kumar Rath S; Boey F; Venkatraman S
    Biomaterials; 2004 Feb; 25(5):813-21. PubMed ID: 14609670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE; Nam YS; Lee KH; Park TG
    J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
    Graves RA; Ledet GA; Glotser EY; Mitchner DM; Bostanian LA; Mandal TK
    Eur J Pharm Sci; 2015 Aug; 76():1-9. PubMed ID: 25933716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.